Business Standard
Thursday, Jan 17, 2013
drived banner
drived banner
  Advanced Search
Content Guide
Follow us on  
||Companies & Industry||||||| 
 Section Home | News Now | Today's Paper | Q&A; | People in the News | Industry News | Features | The Compass | Research & Analysis | Opinion | Corporate Results
Home > Companies & Industry Live Markets | Commodities
Pharma firms boost Wal-Mart revenues
Joe C Mathew / New Delhi June 16, 2008, 5:04 IST

Ranbaxy, Cipla and other Indian drug makers are helping US retailer Wal-Mart sell drugs at low cost and boost revenue.

Indian companies say the low-cost medicine revolution kicked off by Wal-Mart covers medicines meant for cholesterol and heart problems, diabetes, antibiotics, fungal infections, among others.

Wal-Mart's $4 Prescription Program, which covers up to 95 per cent of the prescriptions generated in majority of therapeutic categories in the US, provides its customers over 350 prescription medicines for just $4 (Rs 172) for a month's dose. Last month, Wal-Mart announced an extended Prescription Program, wherein the company offered 90-day prescriptions for $10 (Rs 430). The company says through such programmes, the US consumer has saved over $1 billion.

Wal-Mart did not respond to an email query seeking details of its Indian suppliers.

Meanwhile, for Indian companies that have been waging a price war in the US generic business, supplies to pharmacy chains like Wal-Mart have turned more like their much-famed HIV/AIDS medicine supplies to developing countries in Africa and Latin America.

Indian off-patent medicine manufacturers like Ranbaxy, Dr Reddy's and Sun Pharma, Glenmark are all among the list of suppliers to US pharmacy chains, including Wal-Mart Stores, it is learnt.

According to the Pharmaceutical Export Promotion Council (Pharmexcil), while the volume of medicine exports to the US is increasing, the realisation is on the decline.

"The generic drug prices in the US market have substantially gone down with Indian generic players quoting low prices. This has led to a top departmental store offering to supply of medicines for cardio-vascular ailments, diabetes and antibiotics for $4 for one whole month. It is good to see that the quality of Indian generic products are accepted in the US," P V Appaji, executive director, Pharmexcil, said.

The ability of Indian companies to penetrate into the global generic space and the decision of governments, even in developed countries, to prefer generics to branded products is among the major attractions that make Indian companies potential targets of the Ranbaxy-Daiichi model acquisitions, industry experts said.

New Ipad Application :Business Standard's all new IPad App
Click here to download for free
Arrow Other Stories     
- Pre-Markets: Shares seen opening higher, HCL Tech, Hero MotoCorp eyed
- US FAA grounds Boeing 787 over battery concerns
- Smarter infrastructure spending needed for growth: study
- Nearly $1 trillion of debt at risk of downgrade to junk in 2012: S&P;
- Boeing 787 output, review threatened if engineers strike
  Read Business news in 
- Experience North America like never before. Click here
- India's No. 1 Property Site. Click here to know more
- You Could Win a Polo or a Vento in the 13th minute of any Hour.
- Mobile Number Portability Get Idea without Changing Number. Know more
- Flight Offers - Our Cheapest fares to London. Click here
- Deploy Applications on-premises or in the Cloud. Learn More.
- Creating Sustainable Homes, Cities and Happiness! Click here
- Ring in Celebrations with the gift of office. Click here know more
Sorry, comments to this story are closed
Latest Messages
Most Popular
- Flying from Mumbai to be costlier
- Chidambaram woos states on GST
- Tension with Pak to wound medical tourism industry
- Bajaj Auto net goes up 3% but margins shrink
- Fiat India to help parent company develop smallest Jeep
Spectrum Grab
  Now available at Special price
  Rs. 280/- Only

  Buy Now
Should India offer a military response to Pakistan over the killing of its soldiers?
Table for Two
  Now available at Special price
  Rs.280/- Only

  Buy Now
  Member Area Write to the Editor RSS Advanced Search Portfolio Tracker
  Subscribe to print product Business-standard(Daily) Indian Management BS Motoring Economy & Industry
  Subscribe to online product Newsletter Archives
  BS Products BS Hindi BS Motoring BS Books BS e-paper
Home | Markets & Investing | Companies & Industry | Banking & Finance | Economy & Policy | Opinion
Life & Leisure | Management & Marketing | Tech World | General News
About Us | Partner With Us | Code of Conduct | Careers | Advertise with us| Terms & Conditions | Disclaimer | Contact Us